Computer-Aided Drug Design Methods.

Area of Science:

• Computational chemistry and drug discovery
• Medicinal chemistry and pharmacology
• Microbiology and infectious diseases

Background:

• Computer-aided drug design (CADD) aids in interpreting and guiding experimental research for faster antibiotic development.
• Structure-based drug design (SBDD) and ligand-based drug design (LBDD) are the primary CADD methodologies.
• Understanding target structures and ligand-activity relationships is crucial for designing effective antibiotics.

Purpose of the Study:

• To present standard computational approaches for antibiotic drug discovery.
• To focus on methodologies and targets commonly employed in laboratory settings for identifying new antibiotics.
• To elucidate the principles of SBDD and LBDD in the context of antimicrobial drug development.

Main Methods:

• Structure-based drug design (SBDD) analyzes 3D structures of biological targets (proteins, RNA) to identify interaction sites.
• Ligand-based drug design (LBDD) establishes structure-activity relationships (SAR) from known ligands to guide drug optimization.
• Protocols for both SBDD and LBDD, as applied in the authors' laboratory, are detailed.

Main Results:

• SBDD enables the design of drugs that interfere with essential microbial biological pathways by targeting key interactions.
• LBDD facilitates the optimization of existing drugs and the design of new ones with enhanced activity based on SAR.
• The presented methodologies are routinely used for antibiotic drug discovery in the laboratory.

Conclusions:

• CADD, encompassing SBDD and LBDD, is a powerful strategy for accelerating the discovery of novel antibiotics.
• These computational approaches provide valuable insights for experimental design and lead optimization in antimicrobial research.
• The chapter offers practical insights into applying SBDD and LBDD for identifying new therapeutic agents against microbial pathogens.